Examples of Projects
Carried out a pan-European survey of the market for a
bio-artificial liver. In the course of this project we estimated the market
potential for the device in several market segments and interviewed over
fifty liver surgeons and specialists, mostly face-to-face, in UK, France,
Germany, Spain and Italy.
Organised, over a five year period,
appropriate links between the client mentioned above and the UK regulatory
system.
Undertook a five country survey of the
European potential for a candidate anti-inflammatory product believed to
have potential in the treatment of burns and severe asthma. Interviews to
determine facts and opinions were conducted, often face-to-face and
sometimes by telephone, with burns units and specialist asthma centres in
UK, France, Germany, Italy and Spain.
Researched distribution companies for an Australian medical devices company
and helped it to establish the core of its European distribution network.
We recommended a short list of candidates, helped in the selection process
of four partners, covering eight countries, and advised on associated
strategic issues.
Managed
the liaison between the European distributors and the principal (above)
while also researching the expansion of the network to bring in additional
partners/countries.
Assessed the current state of the
childhood vaccination programme in the UK for a US based company in the
early stages of developing a needle-less injection system. We provide
continuing strategic advice to this company.
Created
a one-day programme “An introduction to Drug Development” which we present
twice each quarter to scientific and administrative staff in biotechnology
companies in the Cambridge area. This highly regarded programme has
been presented in the Cambridge region, under the auspices of
ERBI, more than thirty
times.
Variants of the programme presented through ERBI have been designed
(customised) for use in other regions. For example, a version with Southern
Hemisphere emphasis has been delivered in New Zealand (for BIO in 2004);
similarly, a version focused on European opportunities was delivered in
Melbourne, Australia in 2002 and in Washington DC in 2003. Other versions
have been delivered in
universites.
Helped
a specialist biologicals manufacturer to enhance its production capability
through identifying organisations willing to enter into partnerships with
it. The client wished to remain anonymous in the research phase and
only declare itself at the time of detailed negotiation. As
consultants we were able to preserve the client’s anonymity.
Identified financing opportunities in
Europe for a US vaccine company preparing for its last round of funding
before a proposed dual listing IPO.
Provided two interim managers (CEO and
Commercial Director) for 12 months to a small company developing novel
applications systems for the agricultural sector.
Carried out technology transfer projects
for development agencies and universities.
Created and delivered a two day
development programme "Financial Awareness for Regulatory Affairs
Professionals".
On behalf of a company with a
novel treatment in the vascular disease field, we researched European
distribution possibilities and introduced the CEO to highly qualified
candidates in UK, France, Germany, Austria and Italy; the partners appointed
as a result of our work have formed the basis for further expansion of the
client's European network.
Client List
Selected clients include:
Private sector
Circe Biomedical Inc, Needle-less Venture Inc, a US
vaccine company, a US anti-inflammatory company, ML Laboratories PLC and its
subsidiary Benest Engineering, Dow Agrosciences, Kikaku America
International, Sandoz, USCOM, Danish Development Finance Corporation, ALC Consultants,
British Institute of Regulatory Affairs.
All-Vascular, AMSR, CBACI, PharmaDynamics.
Public Sector
Scottish Development Agency/Scottish Enterprise, University of Lancaster,
University of Brighton, University of Greenwich, Natural Resources
Institute, Scottish Enterprise Tayside, Grampian Enterprise, Lothian and
Edinburgh Enterprise.
Memberships
Managing Resources was a member for many years of the Biotechnology Industry Organisation
(BIO) and provided members to its Business Development Committee and the
Food and Agriculture Section. Further information about BIO can be found at
www.bio.org.
Managing Resources
is a member of the Eastern Region Biotechnology Initiative (ERBI). Further
information about ERBI can be found at
www.erbi.co.uk.
Managing Resources is also a member of the Cambridge Network,
www.cambridgenetwork.co.uk, which gives it access to the full
range of high technology and service organisations in the leading
entrepreneurial centre in the UK, and arguably in Europe.
Alan Williams is an individual member of Ausbiotech.
